Related Experiment Video

Updated: Aug 7, 2025

Analysis of Liver Microenvironment During Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish
09:27

Analysis of Liver Microenvironment During Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish

Published on: April 1, 2021

3.6K

Hepatocellular carcinoma surveillance in non-alcoholic fatty liver disease - who and how?

Margaret Lp Teng1, Darren Jun Hao Tan2, Cheng Han Ng2

  • 1Division of Gastroenterology and Hepatology, Department of Medicine, National University Health System, Singapore.

Clinical and Molecular Hepatology
|March 14, 2023
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Hepatocellular carcinomaNonalcoholic fatty liver diseaseNonalcoholic steatohepatitisSurveillance

More Related Videos

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.3K
Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
08:41

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

1.2K

Related Experiment Videos

Last Updated: Aug 7, 2025

Analysis of Liver Microenvironment During Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish
09:27

Analysis of Liver Microenvironment During Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish

Published on: April 1, 2021

3.6K
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.3K
Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
08:41

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

1.2K

Related Concept Videos

Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

157
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
157
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

852
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
852
Liver Regeneration01:24

Liver Regeneration

3.3K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
3.3K

Articles linked to this work by shared authors, journal, and citation graph.

Integrating Plain 2D Ultrasound and Clinical Data for Identification of At-Risk MASH: A Multicenter Proof of Concept Study.

Journal of gastroenterology and hepatology·2026

A real-world multicenter study of statins in compensated advanced chronic liver disease on hepatic decompensation and mortality outcomes.

Hepatology international·2026

A multicenter multistate modeling on the natural history of liver decompensation: Longitudinal analysis of 1777 patients.

Hepatology communications·2026

Prevalence of Cancer Across Cardiovascular and Cardiometabolic Conditions: A Systematic Review and Meta-Analysis.

European journal of clinical investigation·2026

Clinical utility of a 30% reduction in VCTE-derived liver stiffness measurement for identifying histologic improvement in MASH.

Hepatology (Baltimore, Md.)·2026

A Changing Paradigm: The Swift Expansion of Adult Living Donor Liver Transplantation for MASH Cirrhosis.

Research square·2026

Long-term hepatic and extrahepatic outcomes in type 2 diabetes: final results of the prospective DM-FibroScan Study.

Clinical and molecular hepatology·2026

O-GlcNAcylation of GSDMD promotes mitochondrial dysfunction and hepatocyte injury in MASLD.

Clinical and molecular hepatology·2026

USP22-mediated phagocytic evasion promotes immune escape in TP53-inactivated hepatocellular carcinoma.

Clinical and molecular hepatology·2026

GLP-1 receptor agonists and adverse outcomes in patients with type 2 diabetes and chronic viral hepatitis.

Clinical and molecular hepatology·2026

Epigenetic and Epitranscriptomic Regulation of Immune Checkpoint Response in Hepatocellular Carcinoma: Mechanisms, Therapeutic Targeting, and Translational Challenges.

Clinical and molecular hepatology·2026

Immunotherapy and targeted therapy plus hepatic arterial infusion chemotherapy for HCC with portal vein tumor thrombosis (CHANCE2504): a nationwide target trial emulation study.

Clinical and molecular hepatology·2026

ALDH2 Suppresses Ferroptosis and Promotes Bortezomib Resistance in Multiple Myeloma Through the KEAP1-NRF2 Feedback Loop.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

TRACER: response-protected cross-domain alignment of cancer pharmacogenomic models with patient tumors.

Briefings in bioinformatics·2026

Time-to-transformation transcriptomic modeling identifies oral squamous cell carcinoma-initiation and SPP1-integrin niche programs in oral leukoplakia.

European journal of oral sciences·2026

A Bibliometric Analysis of Mitochondrial Research in Prostate Cancer: Global Research Trends and Emerging Hotspots (2016-2025).

Journal of visualized experiments : JoVE·2026

Prediction Model with Serum RBP4 and Clinical Features for Postoperative Recurrence of Intrahepatic Bile Duct Stones: A Retrospective Cohort Study.

Journal of visualized experiments : JoVE·2026

Long Non-Coding RNA H19 Protection Against Myocardial Ischemia/Reperfusion Injury in Diabetic Mice Through Hypoxia-Inducible Factor 1 Alpha Signaling.

Journal of visualized experiments : JoVE·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us